Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S.-Israel Tussle Over IP Rights Continues; New Free Trade Policy Is Limited

Executive Summary

The generic pharmaceutical industry won a victory when the United States agreed to loosen intellectual property restrictions in its free trade agreements. But the policy does not apply to every trading partner and some countries continue to battle against terms they say will delay the marketing of low-cost drugs
Advertisement

Related Content

Global IP Protection: Data Exclusivity Is Top USTR Concern As Licensing Recedes
Global IP Protection: Data Exclusivity Is Top USTR Concern As Licensing Recedes
Global IP Protection: U.S. “Priority Watch List” Includes Major Suppliers
Global IP Protection: U.S. “Priority Watch List” Includes Major Suppliers
Intellectual Property Bill Would Sanction Countries That Fail U.S. Rules
Intellectual Property Bill Would Sanction Countries That Fail U.S. Rules
Latin American Trade Agreements Loosen Pharmaceutical IP Rules
Latin American Trade Agreements Loosen Pharmaceutical IP Rules
Advertisement
UsernamePublicRestriction

Register

PS049112

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel